Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/19646
Title: Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia.
Authors: 
Keywords: 
Mesh: 
Issue Date: Feb-2016
Citation: Aging Clin Exp Res.2016 Feb;(28)1:47-58
Abstract: Sarcopenia is an age-related muscle condition which is frequently a precursor of frailty, mobility disability and premature death. It has a high prevalence in older populations and presents a considerable social and economic burden. Potential treatments are under development but, as yet, no guidelines support regulatory studies for new drugs to manage sarcopenia. The objective of this position paper is therefore to suggest a set of potential endpoints and target population definitions to stimulate debate and progress within the medico-scientific and regulatory communities.
PMID: 26717937
URI: https://hdl.handle.net/20.500.12530/19646
Rights: openAccess
Appears in Collections:Fundaciones e Institutos de Investigación > IIS H. U. Ramón y Cajal > Artículos

Files in This Item:
File Description SizeFormat 
PMC4768478.pdf660.67 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.